Michel Vanbrabant, iSTAR Medical - Delivering Breakthrough Eye Care Solutions | LSI Europe '24

MINIject® is iSTAR Medical’s most advanced product, and is approved in Europe for the treatment of Glaucoma – the leading cause of irreversible blindness. Minimally-Invasive Glaucoma Surgery (MIGS) devices are considered the future in glaucoma treatment.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Michel Vanbrabant
Michel Vanbrabant
CEO, iSTAR Medical